For example, preliminary results from the AMATERASU randomized trial suggest that vitamin D supplementation may improve survival in a subgroup of patients with p53-positive tumors of the digestive tract or poorly differentiated adenocarcinoma [216,217]. Here, TP53 is linked to neoplasm.